T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Praxis Precision Medicines
PRAX
$10.6B
| $93M | 0.01% |
1,208,522
+88,442
| +8% | +$6.4M |
|
577
Globus Medical
GMED
$11.5B
| $92.9M | 0.01% |
1,123,132
-9,901
| -0.9% | -$781K |
|
578
Xencor
XNCR
$1.71B
| $92.8M | 0.01% |
4,036,412
+107,350
| +3% | +$2.47M |
|
579
The Ensign Group
ENSG
$10.7B
| $92.5M | 0.01% |
696,061
-105,556
| -13% | -$15.3M |
|
580
Iron Mountain
IRM
$37.4B
| $92.2M | 0.01% |
877,238
+57,104
| +7% | +$6.71M |
|
581
Braze
BRZE
$3.12B
| $92M | 0.01% |
2,197,407
+1,203,149
| +121% | +$43.7M |
|
582
News Corp Class B
NWS
$17.7B
| $91.6M | 0.01% |
3,011,333
-270,830
| -8% | -$8.17M |
|
|
DFS
583
DELISTED
Discover Financial Services
DFS
| $91M | 0.01% |
525,386
-866,821
| -62% | -$142M |
|
584
Leidos
LDOS
$17.7B
| $90.5M | 0.01% |
628,463
-253,961
| -29% | -$42.3M |
|
585
Clorox
CLX
$12.7B
| $90.1M | 0.01% |
554,688
+163,341
| +42% | +$26.7M |
|
586
CoStar Group
CSGP
$12.6B
| $89.9M | 0.01% |
1,256,421
-14,910
| -1% | -$1.13M |
|
587
Celldex Therapeutics
CLDX
$3.41B
| $89.9M | 0.01% |
3,557,136
+676,771
| +23% | +$18.4M |
|
|
CNTA
588
DELISTED
Centessa Pharmaceuticals
CNTA
| $89.9M | 0.01% |
5,364,392
+685,371
| +15% | +$11.4M |
|
589
Delta Air Lines
DAL
$60.2B
| $89.7M | 0.01% |
1,482,161
-470,687
| -24% | -$27.8M |
|
590
Evercore
EVR
$11.6B
| $89.6M | 0.01% |
323,324
+300,032
| +1,288% | +$85M |
|
591
Coca-Cola Consolidated
COKE
$12.7B
| $89.4M | 0.01% |
709,780
-130
| -0% | -$16.3K |
|
|
HOLX
592
DELISTED
Hologic
HOLX
| $88.7M | 0.01% |
1,229,855
-1,572,074
| -56% | -$123M |
|
593
Disc Medicine
IRON
$3.06B
| $88.4M | 0.01% |
1,394,637
+262,690
| +23% | +$15.2M |
|
594
Kanzhun
BZ
$6.87B
| $87.7M | 0.01% |
6,355,463
-6,471,901
| -50% | -$95.2M |
|
595
On Holding
ONON
$10.3B
| $87.7M | 0.01% |
1,600,649
+79,680
| +5% | +$4.22M |
|
596
Payoneer
PAYO
$2.42B
| $87.5M | 0.01% |
8,709,989
+440,231
| +5% | +$4.21M |
|
597
Onto Innovation
ONTO
$20.9B
| $87.3M | 0.01% |
523,674
-40,338
| -7% | -$7.37M |
|
598
T. Rowe Price Equity Income ETF
TEQI
$470M
| $86.6M | 0.01% |
2,134,101
+484,100
| +29% | +$20.3M |
|
599
LPL Financial
LPLA
$29.4B
| $86M | 0.01% |
263,268
-352,717
| -57% | -$104M |
|
600
Aflac
AFL
$60.6B
| $85.3M | 0.01% |
824,947
+23,455
| +3% | +$2.56M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.